Copyright © 2014 American Medical Association. All rights reserved.

Slides:



Advertisements
Similar presentations
Professor Abdus Samad MD FACC Karachi Institute of Heart Diseases Karachi, Pakistan May 1, 2010.
Advertisements

Arterial Revascularization Therapies Part II: a non- randomized comparison of contemporary PCI and coronary artery bypass grafting (CABG) in patients with.
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Risk of Mortality and End-Stage Renal Disease.
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Quality of Life After PCI vs CABG Among Patients.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prospective Application of Pre-Defined Intravascular.
Date of download: 5/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Aspirin for the Prevention of Cardiovascular Events.
Date of download: 5/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Elective Intra-aortic Balloon Counterpulsation During.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Varespladib and Cardiovascular Events in Patients.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Menopausal Hormone Therapy and Health Outcomes During.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effect of Clopidogrel Pretreatment Before Percutaneous.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Survival of patients with diabetes and multivessel.
Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11): doi: /
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Frequency and Practice-Level Variation in Inappropriate.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Smoking Is Associated With Adverse Clinical Outcomes.
Date of download: 6/22/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association Between Influenza Vaccination and Cardiovascular.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Percutaneous Coronary Intervention Complications.
Date of download: 7/5/2016 From: Validation of the Appropriate Use Criteria for Coronary Angiography: A Cohort Study Ann Intern Med. 2015;162(8):
Date of download: 7/6/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Prognostic Importance of Physical Examination for.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Fractional Flow Reserve Versus Angiography for Guiding.
Date of download: 7/8/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Reduced-Function CYP2C19 Genotype and Risk of Adverse.
Date of download: 7/8/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Troponin Criteria for Myocardial Infarction After.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA guidelines for percutaneous coronary intervention.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Making Sense of Statistics in Clinical Trial Reports:
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Risk of Stroke With Coronary Artery Bypass Graft.
Date of download: 9/16/2016 Copyright © The American College of Cardiology. All rights reserved. From: 5-Year Clinical Outcomes of the ARTS II (Arterial.
From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence and Correlates of Drug-Eluting Stent Thrombosis.
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association Between Endoscopic vs Open Vein-Graft.
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Public Reporting for Percutaneous.
Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Characteristics and Long-Term Outcomes of Percutaneous.
From: Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention:
Copyright © 2005 American Medical Association. All rights reserved.
Copyright © 2011 American Medical Association. All rights reserved.
From: Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery Ann Intern Med.
Copyright © 2006 American Medical Association. All rights reserved.
Subgroup analyses for mortality after treatment with coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI). LAD, left anterior.
Copyright © 2012 American Medical Association. All rights reserved.
Copyright © 2012 American Medical Association. All rights reserved.
Arch Intern Med. 2004;164(13): doi: /archinte Figure Legend:
Copyright © 2013 American Medical Association. All rights reserved.
Figure 3 One-year adverse events (death, post-discharge myocardial infarction, revascularization) after PCI according to patients who (A) would not have.
Copyright © 2000 American Medical Association. All rights reserved.
Copyright © 2005 American Medical Association. All rights reserved.
Copyright © 2012 American Medical Association. All rights reserved.
Ann Intern Med. 2009;150(11): doi: / Figure Legend:
Copyright © 2014 American Medical Association. All rights reserved.
From: Quantitative Synthesis in Systematic Reviews
Copyright © 2008 American Medical Association. All rights reserved.
Copyright © 2007 American Medical Association. All rights reserved.
Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention  Chirag Bavishi, MD, MPH,
Percutaneous coronary invervention versus coronary artery bypass grafting: A meta- analysis  Yolba Smit, MD, MSc, Joan Vlayen, MD, Hetty Koppenaal, MD,
Pre-existing psychological depression confers increased risk of adverse cardiovascular outcomes following cardiac surgery: A systematic review and meta-analysis 
Do higher-risk patients benefit from off-pump coronary artery bypass grafting? Evidence from an ecologic analysis of randomized trials  Oliver Kuss, PhD,
Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies  Hisato Takagi,
Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);
Myocardial Revascularization for Patients With Diabetes: Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention?  Serenella Castelvecchio,
Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.
Why surgery won the SYNTAX trial and why it matters
Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris  Toshihiro Fukui,
Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD 
A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned  Robert E.
Do the EXCEL and NOBLE Trial Results Change Meta-Analysis Findings?
Yin-Shu Chang, MD, Jia-Xiang Wang, MD, PhD, Da-Wei Chang, PhD 
Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: A meta-analysis of randomized and nonrandomized.
Stent Versus Off-Pump Coronary Bypass Grafting in the Second-Generation Drug- Eluting Stent Era  Gijong Yi, MD, PhD, Hyun-Chel Joo, MD, Young-Nam Youn,
Cox regression of proportion mortality in the first 8 years for patients with three-vessel disease with a significant difference between the treatment.
Figures showing the effects of a potential 30% relative reduction in events with next-generation drug-eluting stents in the percutaneous coronary intervention.
Effect of PCI on 3 to 5-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval.
Kaplan-Meier estimate of mortality in the two treatment strategies with significant difference between the two groups (log-rank test
Presentation transcript:

Copyright © 2014 American Medical Association. All rights reserved. From: Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention and Long-term Mortality and Morbidity in Multivessel DiseaseMeta-analysis of Randomized Clinical Trials of the Arterial Grafting and Stenting Era JAMA Intern Med. 2014;174(2):223-230. doi:10.1001/jamainternmed.2013.12844 Figure Legend: Flowchart of Trials Included in the Meta-analysisFor study acronym expansions, see the cited references. Date of download: 10/3/2017 Copyright © 2014 American Medical Association. All rights reserved.

Copyright © 2014 American Medical Association. All rights reserved. From: Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention and Long-term Mortality and Morbidity in Multivessel DiseaseMeta-analysis of Randomized Clinical Trials of the Arterial Grafting and Stenting Era JAMA Intern Med. 2014;174(2):223-230. doi:10.1001/jamainternmed.2013.12844 Figure Legend: Funnel Plots Examining Publication Bias for Mortality (A) and Myocardial Infarction (B)Log risk ratios less than 0 favor coronary artery bypass grafting; those greater than 0 favor percutaneous coronary intervention. These funnel plots represent a measure of study size on the vertical axis as a function of effect size on the horizontal axis. Large studies appear toward the top of the graph, and tend to cluster near the mean effect size. Smaller studies appear toward the bottom of the graph and (since there is more sampling variation in effect size estimates in the smaller studies) will be dispersed across a range of values. In the absence of publication bias, as is demonstrated in these funnel plots, the studies, represented by pale dotted circles, are distributed symmetrically about the combined effect size. The dashed diamond appearing below the x-axis represents the summary effect. Date of download: 10/3/2017 Copyright © 2014 American Medical Association. All rights reserved.

Copyright © 2014 American Medical Association. All rights reserved. From: Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention and Long-term Mortality and Morbidity in Multivessel DiseaseMeta-analysis of Randomized Clinical Trials of the Arterial Grafting and Stenting Era JAMA Intern Med. 2014;174(2):223-230. doi:10.1001/jamainternmed.2013.12844 Figure Legend: Mortality According to Treatment ArmTotal number of patients, 6055 (I2 = 0% for the fixed effects model). CABG indicates coronary artery bypass graft; PCI, percutaneous coronary intervention; RR, risk ratio; for expansion of all study name acronyms, see the cited references. Date of download: 10/3/2017 Copyright © 2014 American Medical Association. All rights reserved.

Copyright © 2014 American Medical Association. All rights reserved. From: Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention and Long-term Mortality and Morbidity in Multivessel DiseaseMeta-analysis of Randomized Clinical Trials of the Arterial Grafting and Stenting Era JAMA Intern Med. 2014;174(2):223-230. doi:10.1001/jamainternmed.2013.12844 Figure Legend: Myocardial Infarctions (MIs) According to Treatment ArmTotal number of patients, 5067 (I2 = 8.02% for the fixed effects model). CABG indicates coronary artery bypass graft; PCI, percutaneous coronary intervention; RR, risk ratio; for expansion of all study name acronyms, see the cited references. Date of download: 10/3/2017 Copyright © 2014 American Medical Association. All rights reserved.

Copyright © 2014 American Medical Association. All rights reserved. From: Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention and Long-term Mortality and Morbidity in Multivessel DiseaseMeta-analysis of Randomized Clinical Trials of the Arterial Grafting and Stenting Era JAMA Intern Med. 2014;174(2):223-230. doi:10.1001/jamainternmed.2013.12844 Figure Legend: Strokes According to Treatment ArmTotal number of patients, 5067 (I2 = 24.9% for the fixed effects model). CABG indicates coronary artery bypass graft; PCI, percutaneous coronary intervention; RR, risk ratio; for expansion of all study name acronyms, see the cited references. Date of download: 10/3/2017 Copyright © 2014 American Medical Association. All rights reserved.

Copyright © 2014 American Medical Association. All rights reserved. From: Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention and Long-term Mortality and Morbidity in Multivessel DiseaseMeta-analysis of Randomized Clinical Trials of the Arterial Grafting and Stenting Era JAMA Intern Med. 2014;174(2):223-230. doi:10.1001/jamainternmed.2013.12844 Figure Legend: Repeat Revascularizations According to Treatment ArmTotal number of patients, 6055 (I2 = 75.6% for the random effects model). CABG indicates coronary artery bypass graft; PCI, percutaneous coronary intervention; RR, risk ratio; for expansion of all study name acronyms, see the cited references. Date of download: 10/3/2017 Copyright © 2014 American Medical Association. All rights reserved.

Copyright © 2014 American Medical Association. All rights reserved. From: Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention and Long-term Mortality and Morbidity in Multivessel DiseaseMeta-analysis of Randomized Clinical Trials of the Arterial Grafting and Stenting Era JAMA Intern Med. 2014;174(2):223-230. doi:10.1001/jamainternmed.2013.12844 Figure Legend: Major Adverse Cardiovascular and Cerebrovascular Events (MACCE) According to Treatment ArmTotal number of patients, 4659 (I2 = 33.0% for the fixed effects model). CABG indicates coronary artery bypass graft; PCI, percutaneous coronary intervention; RR, risk ratio; for expansion of all study name acronyms, see the cited references. Date of download: 10/3/2017 Copyright © 2014 American Medical Association. All rights reserved.